Health Care/Hospital
BTL Establishes New Laser Division and Introduces EXOLASE ONE® - The World's First Fused Erbium Laser
Proprietary technology fuses multiple wavelengths into a single beam to set a new standard of care in laser facial rejuvenation. PRAGUE, Sept. 2, 2026 /PRNewswire/ -- BTL, a global leader in advanced energy-based medical and aesthetic technologies, today announced a major milestone in its corpor...
2026-09-02 16:00
2090
Singapore has cut stroke mortality by up to six-fold since the 1990s, but public awareness remains the final hurdle, new report finds
Singaporean experts call for renewed public education on the FAST warning signs and continued investment in specialist staffing to sustain the country's world-leading stroke outcomes. SINGAPORE, Sept. 2, 2026 /PRNewswire/ -- Singapore has cut stroke mortality by up to six-fold since the 1990s[1]...
2026-09-02 15:00
5187
Despite nationwide basic stroke treatment coverage, delays accessing advanced stroke care in Vietnam vary by region, new report finds
Patients in Vietnam's Southwest region and Mekong Delta can travel up to ten hours for advanced stroke care; Vietnamese experts point to a public-private model in Can Tho as a way to close that gap. HO CHI MINH CITY, Vietnam, Sept. 2, 2026 /PRNewswire/ -- Delays occurring before patients reach a...
2026-09-02 15:00
4801
Workforce shortages and limited public hospital capacity remain major barriers to stroke care in the Philippines, new report finds
Filipino experts call for equipping more public hospitals with advanced imaging technology, stronger EMS infrastructure and greater investment in specialist training to close these gaps MANILA, Philippines, Sept. 2, 2026 /PRNewswire/ -- Workforce shortages and limited public hospital capacity re...
2026-09-02 15:00
5148
Delays before patients reach stroke centres remain a major barrier to timely treatment in Malaysia, new report finds
Malaysia experts call for better public awareness of stroke symptoms, standardised hospital imaging protocols and expanded access to specialist care beyond major urban centres KUALA LUMPUR, Malaysia, Sept. 2, 2026 /PRNewswire/ -- Delays occurring before patients reach stroke centres remain a maj...
2026-09-02 15:00
5263
Delays Before Patients Reach Stroke Centers Still Hinder Timely Treatment Across Southeast Asia, Siemens Healthineers Report Finds
New research commissioned by Siemens Healthineers shows transportation delays, slow reporting processes as leading barriers to timely stroke diagnosis. * Stronger referral networks, public awareness, AI-enabled diagnostics, coordinated care are key to strengthening stroke system readiness acros...
2026-09-02 15:00
5174
"From Canine Fat Tissue to Insulin-Producing Cells": Chula Veterinary Researchers Offer New Hope for Diabetes Treatment in Pets
While diabetes is commonly associated with humans, the disease also affects dogs and cats. Its impact on the quality of life of both pets and their owners is often greater than many people realize. BANGKOK, Sept. 2, 2026 /PRNewswire/ -- In dogs, diabetes is similar to Type 1 diabetes in humans, ...
2026-09-02 14:23
3267
Smartee Expands Pediatric Orthodontic Education Initiatives in Asia Pacific Through Clinical Exchange
SINGAPORE, Aug. 31, 2026 /PRNewswire/ -- Smartee Denti-Technology recently brought together dental professionals for the Smartee Kinder & Teen Workshop, an educational program focused on the clinical assessment and management of growing patients. Held under the theme "Children's Early Orthodonti...
2026-09-02 10:38
2630
HEC Group Enters Strategic Partnerships in Macau to Advance the Internationalization of Cordyceps Sinensis
MACAU, Sept. 2, 2026 /PRNewswire/ -- HEC Group has entered into strategic partnerships with MCCY Science & Greater Health Manufactory (operating regionally as Seed Scientific Research International Limited) and Longtai Health to strengthen the production, commercialization and international deve...
2026-09-02 10:00
2453
Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to participate in trial for innovative mapping and pulsed field ablation system
AUSTIN, Texas, Sept. 2, 2026 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first facility in the nation to participate in a clinical trial to evaluate the safety and effectiveness of a next-generation mapping and pulsed field ablat...
2026-09-02 09:37
2366
Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway
* The Phase 3 BiPASS™ study of Illuccix® and Gozellix® for prostate cancer imaging in the pre-biopsy setting has completed enrollment of 350 patients. * Telix has positively engaged with the FDA on a New Drug Application (NDA) pathway in the U.S. that would support new product reimbursement an...
2026-09-02 09:27
2155
Zepp Health Corporation Reports Second Quarter of 2026 Unaudited Financial Results
MILPITAS, Calif., Sept. 1, 2026 /PRNewswire/ -- Zepp Health Corporation (NYSE: ZEPP) ("Zepp", the "Company" or "we") today announced its unaudited financial results for the second quarter of 2026. Second Quarter of 2026 Financial and Operating Highlights: * Revenue reached US$63.5 million, rep...
2026-09-02 09:00
5520
Haier Biomedical Highlights Automated Biostorage and Connected Pharma Solutions at ISPE Singapore 2026
Haier Biomedical Accelerates Its Transformation into an Intelligent
Biopharmaceutical Infrastructure Platform at ISPE Singapore 2026
SINGAPORE, Sept. 1, 2026 /PRNewswire/ -- Haier Biomedical
2026-09-01 22:50
3379
Super MOXI® by Sciton Ushers in a New Era of Head-to-Toe Skin Revitalization
PALO ALTO, Calif., Sept. 1, 2026 /PRNewswire/ -- Sciton Inc., a pioneer and leader in medical and aesthetic laser and light-based technologies, today announced the launch of Super MOXI® with High Density (HD) Delivery™, a major evolution of its award-winning MOXI® laser that brings new speed, ver...
2026-09-01 21:10
2830
Suki Named a Transformational Innovation Leader in Ambient Clinical Intelligence by Frost & Sullivan
2026 recognition highlights Suki's innovation, clinical quality and measurable
impact as Ambient Clinical Intelligence expands across the enterprise
SAN ANTONIO, Sept. 1, 2026 /PRNewswire/ -- Suki
2026-09-01 21:00
1935
Simcere Zaiming Enters Exclusive License Agreement with Roche for SIM0660 Global Development
NANJING, China, Sept. 1, 2026 /PRNewswire/ -- Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group (2096.HK) today announced that it has entered into an exclusive global licensing agreement with Roche for the development and commercialization of SIM0660, a tri-specific antibody targeting...
2026-09-01 20:28
3280
Time is Running Out to Submit a Claim in the Asbestos Corporation Limited insolvency proceedings
The deadline is September 10, 2026. NEW YORK, Sept. 1, 2026 /PRNewswire/ -- The following statement is being issued by Kroll Restructuring Administration and Raymond Chabot Inc. regarding the Asbestos Corporation Limited insolvency proceedings. With less than one month remaining before the Septe...
2026-09-01 20:13
2686
QC Ware and IonQ Demonstrate High-Precision Hybrid Quantum Workflow for Drug Discovery
Joint test on IonQ Forte hardware lands within 4% of benchmark, clearing the chemical-accuracy bar for enzyme active-site modeling via Amazon Braket PALO ALTO, Calif., Sept. 1, 2026 /PRNewswire/ -- QC Ware today announced a technology demonstration of a hybrid quantum-classical chemistry workflow...
2026-09-01 20:00
2379
Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy
Paxalisib Monotherapy Significantly Reduced Tumor Burden in Pre-Clinical Model of MSS/pMMR Colorectal Cancer, With the Addition of Pembrolizumab Driving a Further Reduction Paxalisib Was Well Tolerated as Monotherapy and in Combination with Checkpoint Inhibition Kazia is Preparing to Advance Pa...
2026-09-01 19:30
2215
Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer
Preclinical Data Show Paxalisib Combined With Standard-of-Care Therapy Is Well Tolerated and Produces Statistically Significant Antitumor Activity Three-Arm Expansion of the Ongoing TNBC Trial Will Evaluate Paxalisib Plus Fulvestrant, With Palbociclib, Versus Standard-of-Care First Patient Expec...
2026-09-01 19:15
2468
Week's Top Stories
Most Reposted
HLB's Flagship CIO Fund Launched with Strategic Alliance with Lombard Odier
[Picked up by 281 media titles]
2026-09-28 23:04
Responsible Fintech Institute Appoints Four Executive Fellows and Elevates Distinguished Professor Patrick H. M. Loh to Co-Founder
[Picked up by 279 media titles]
2026-09-29 09:00
Allianz Partners unveils next-generation travel insurance platform to help partners navigate changing landscape
[Picked up by 269 media titles]
2026-09-28 07:30
ViewSonic Launches VG1457 Dual-Screen Portable Monitor for Productivity Anywhere
[Picked up by 267 media titles]
2026-09-30 10:50
Zenika CTO Adrien Nortain Moves Base to Singapore to Strengthen Technical Leadership in Asia
[Picked up by 267 media titles]
2026-10-01 10:00
Most Read
MixVio AI Launches Unified Creative Workspace Across 26 AI Generation Routes
2026-10-02 00:30
22803
Toshiba Information Equipment (Philippines) Celebrates 30th Anniversary and First Shipment from Expanded Nearline HDD Production Line
2026-10-02 21:14
8628
